BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12499127)

  • 21. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
    Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
    Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244
    [No Abstract]   [Full Text] [Related]  

  • 25. Raloxifene: bone and cardiovascular effects.
    Francucci CM; Romagni P; Boscaro M
    J Endocrinol Invest; 2005; 28(10 Suppl):85-9. PubMed ID: 16550730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
    Pfeilschifter J
    Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drugs in development for the treatment of osteoporosis:Raloxifene].
    Taga M
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():572-80. PubMed ID: 11979956
    [No Abstract]   [Full Text] [Related]  

  • 28. Alendronic acid in primary prevention: new indication. No reduction in fracture risk.
    Prescrire Int; 2000 Jun; 9(47):70-2. PubMed ID: 11010741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half].
    MMW Fortschr Med; 2003 May; 145(22):57. PubMed ID: 12866287
    [No Abstract]   [Full Text] [Related]  

  • 31. [Who are the candidates for the treatment by raloxifen ?].
    Hagino H
    Clin Calcium; 2004 Oct; 14(10):111-3. PubMed ID: 15577141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M
    Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract]   [Full Text] [Related]  

  • 33. [Selective estrogen receptor modulators (SERM's) in postmenopausal women].
    Kleiverda G
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2446-7. PubMed ID: 10608980
    [No Abstract]   [Full Text] [Related]  

  • 34. Compliance of osteoporotic patients with different treatment regimens.
    Segal E; Tamir A; Ish-Shalom S
    Isr Med Assoc J; 2003 Dec; 5(12):859-62. PubMed ID: 14689753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of osteoporosis with antiresorptive drugs].
    Vestergaard P; Mosekilde L; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840
    [No Abstract]   [Full Text] [Related]  

  • 36. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL; Chao HT; Cheng MH; Wang PH
    Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
    [No Abstract]   [Full Text] [Related]  

  • 38. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
    Delaney MF
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis.
    American Association of Clinical Endocrinologists Osteoporosis Task Force
    Endocr Pract; 2001; 7(4):293-312. PubMed ID: 11508261
    [No Abstract]   [Full Text] [Related]  

  • 40. Latest innovation in the treatment of osteoporosis: SERMs and the role of parathyroid hormone.
    Thiebaud D
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S124-5. PubMed ID: 21213508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.